Cyanosis primary prevention: Difference between revisions
Jump to navigation
Jump to search
Kiran Singh (talk | contribs) |
|||
| (10 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cyanosis}} | {{Cyanosis}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
Effective measurement for primary prevention include prenatal [[echocardiography]] and [[genetic]] testing for detecting [[cyanotic congenital heart disease]] and prenatal [[corticosteroid]] therapy for prevention of neonatal [[respiratory distress syndrome]] and development of lung maturation. | |||
== Primary prevention == | |||
*Effective measurement for primary prevention include prenatal [[echocardiography]] and [[genetic]] testing for detecting [[cyanotic congenital heart disease]] and prenatal [[corticosteroid]] therapy for prevention of neonatal [[respiratory distress syndrome]] and development of lung maturation.<ref name="LiuXu2019">{{cite journal|last1=Liu|first1=Xiwang|last2=Xu|first2=Weize|last3=Yu|first3=Jiangen|last4=Shu|first4=Qiang|title=Screening for congenital heart defects: diversified strategies in current China|journal=World Journal of Pediatric Surgery|volume=2|issue=1|year=2019|pages=e000051|issn=2516-5410|doi=10.1136/wjps-2019-000051}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 17:55, 6 November 2020
|
Cyanosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cyanosis primary prevention On the Web |
|
American Roentgen Ray Society Images of Cyanosis primary prevention |
|
Risk calculators and risk factors for Cyanosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measurement for primary prevention include prenatal echocardiography and genetic testing for detecting cyanotic congenital heart disease and prenatal corticosteroid therapy for prevention of neonatal respiratory distress syndrome and development of lung maturation.
Primary prevention
- Effective measurement for primary prevention include prenatal echocardiography and genetic testing for detecting cyanotic congenital heart disease and prenatal corticosteroid therapy for prevention of neonatal respiratory distress syndrome and development of lung maturation.[1]
References
- ↑ Liu, Xiwang; Xu, Weize; Yu, Jiangen; Shu, Qiang (2019). "Screening for congenital heart defects: diversified strategies in current China". World Journal of Pediatric Surgery. 2 (1): e000051. doi:10.1136/wjps-2019-000051. ISSN 2516-5410.